264 related articles for article (PubMed ID: 19620237)
1. Signal transduction of the CB1 cannabinoid receptor.
Turu G; Hunyady L
J Mol Endocrinol; 2010 Feb; 44(2):75-85. PubMed ID: 19620237
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid receptor signaling.
Howlett AC
Handb Exp Pharmacol; 2005; (168):53-79. PubMed ID: 16596771
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid signalling.
Demuth DG; Molleman A
Life Sci; 2006 Jan; 78(6):549-63. PubMed ID: 16109430
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid signalling in the enteric nervous system.
Galligan JJ
Neurogastroenterol Motil; 2009 Sep; 21(9):899-902. PubMed ID: 19689654
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor differentially augments G(i)-mediated stimulation of c-Jun N-terminal kinase activity.
Chan AS; Wong YH
Br J Pharmacol; 2004 Jun; 142(4):635-46. PubMed ID: 15172963
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor homo- and heterodimerization.
Mackie K
Life Sci; 2005 Aug; 77(14):1667-73. PubMed ID: 15978631
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptors in submandibular acinar cells: functional coupling between saliva fluid and electrolytes secretion and Ca2+ signalling.
Kopach O; Vats J; Netsyk O; Voitenko N; Irving A; Fedirko N
J Cell Sci; 2012 Apr; 125(Pt 8):1884-95. PubMed ID: 22366450
[TBL] [Abstract][Full Text] [Related]
8. D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor.
Jarrahian A; Watts VJ; Barker EL
J Pharmacol Exp Ther; 2004 Mar; 308(3):880-6. PubMed ID: 14634050
[TBL] [Abstract][Full Text] [Related]
9. Role of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinase kinase in adenosine A2B receptor-mediated interleukin-8 production in human mast cells.
Feoktistov I; Goldstein AE; Biaggioni I
Mol Pharmacol; 1999 Apr; 55(4):726-34. PubMed ID: 10101031
[TBL] [Abstract][Full Text] [Related]
10. [Studies on cell signaling immunomodulated murine peritoneal suppressor macrophages: LPS and PMA mediate the activation of RAF-1, MAPK p44 and MAPK p42 and p38 MAPK].
Chang ZL; Lin MQ; Wang MZ; Yao Z
Shi Yan Sheng Wu Xue Bao; 1997 Mar; 30(1):73-81. PubMed ID: 10684111
[TBL] [Abstract][Full Text] [Related]
11. Type I cannabinoid receptor trafficking: all roads lead to lysosome.
Rozenfeld R
Traffic; 2011 Jan; 12(1):12-8. PubMed ID: 21040297
[TBL] [Abstract][Full Text] [Related]
12. Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview.
Basavarajappa BS; Hungund BL
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):287-99. PubMed ID: 12052043
[TBL] [Abstract][Full Text] [Related]
13. The CB1 cannabinoid receptor in the brain.
Howlett AC
Neurobiol Dis; 1998 Dec; 5(6 Pt B):405-16. PubMed ID: 9974174
[TBL] [Abstract][Full Text] [Related]
14. The signalling profile of recombinant human orexin-2 receptor.
Tang J; Chen J; Ramanjaneya M; Punn A; Conner AC; Randeva HS
Cell Signal; 2008 Sep; 20(9):1651-61. PubMed ID: 18599270
[TBL] [Abstract][Full Text] [Related]
15. Ligand- and heterodimer-directed signaling of the CB(1) cannabinoid receptor.
Hudson BD; Hébert TE; Kelly ME
Mol Pharmacol; 2010 Jan; 77(1):1-9. PubMed ID: 19837905
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging.
Yao BB; Hsieh G; Daza AV; Fan Y; Grayson GK; Garrison TR; El Kouhen O; Hooker BA; Pai M; Wensink EJ; Salyers AK; Chandran P; Zhu CZ; Zhong C; Ryther K; Gallagher ME; Chin CL; Tovcimak AE; Hradil VP; Fox GB; Dart MJ; Honore P; Meyer MD
J Pharmacol Exp Ther; 2009 Jan; 328(1):141-51. PubMed ID: 18931146
[TBL] [Abstract][Full Text] [Related]
17. The type 1 cannabinoid receptor is highly expressed in embryonic cortical projection neurons and negatively regulates neurite growth in vitro.
Vitalis T; Lainé J; Simon A; Roland A; Leterrier C; Lenkei Z
Eur J Neurosci; 2008 Nov; 28(9):1705-18. PubMed ID: 18973587
[TBL] [Abstract][Full Text] [Related]
18. Presynaptic modulation by endocannabinoids.
Lovinger DM
Handb Exp Pharmacol; 2008; (184):435-77. PubMed ID: 18064422
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid CB(1) and adenosine A(1) receptors independently inhibit hippocampal synaptic transmission.
Serpa A; Ribeiro JA; Sebastião AM
Eur J Pharmacol; 2009 Nov; 623(1-3):41-6. PubMed ID: 19782066
[TBL] [Abstract][Full Text] [Related]
20. CB(1) cannabinoid receptors and their associated proteins.
Howlett AC; Blume LC; Dalton GD
Curr Med Chem; 2010; 17(14):1382-93. PubMed ID: 20166926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
